Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
6.80
+0.25 (3.82%)
At close: Jul 14, 2025, 4:00 PM
6.80
0.00 (0.00%)
After-hours: Jul 14, 2025, 4:00 PM EDT
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $239.75 million as of July 14, 2025. Its market cap has decreased by -53.78% in one year.
Market Cap
239.75M
Enterprise Value
-94.59M
1-Year Change
-53.78%
Ranking
Category
Stock Price
$6.80
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has decreased from $251.01M to $239.75M, a decrease of -4.49%. That is a compound annual growth rate of -1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 230.93M | -62.28% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |